Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Studies

Pharmacokinetics and Normal Organ Dosimetry Following Intraperitoneal Rhenium-186-Labeled Monoclonal Antibody

Hazel B. Breitz, James S. Durham, Darrell R. Fisher, Paul L. Weiden, Gerald L. DeNardo, Henry M. Goodgold and Wil B. Nelp
Journal of Nuclear Medicine May 1995, 36 (5) 754-761;
Hazel B. Breitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James S. Durham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darrell R. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Weiden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald L. DeNardo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry M. Goodgold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wil B. Nelp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 36, Issue 5
May 1, 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacokinetics and Normal Organ Dosimetry Following Intraperitoneal Rhenium-186-Labeled Monoclonal Antibody
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pharmacokinetics and Normal Organ Dosimetry Following Intraperitoneal Rhenium-186-Labeled Monoclonal Antibody
Hazel B. Breitz, James S. Durham, Darrell R. Fisher, Paul L. Weiden, Gerald L. DeNardo, Henry M. Goodgold, Wil B. Nelp
Journal of Nuclear Medicine May 1995, 36 (5) 754-761;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pharmacokinetics and Normal Organ Dosimetry Following Intraperitoneal Rhenium-186-Labeled Monoclonal Antibody
Hazel B. Breitz, James S. Durham, Darrell R. Fisher, Paul L. Weiden, Gerald L. DeNardo, Henry M. Goodgold, Wil B. Nelp
Journal of Nuclear Medicine May 1995, 36 (5) 754-761;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Intraperitoneal {alpha}-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study
  • Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity
  • Google Scholar

More in this TOC Section

  • Characterization of Pulmonary and Myocardial Beta-Adrenoceptors with S-1′-[Fluorine-18]Fluorocarazolol
  • Detection of Postoperative Deep-Venous Thrombosis Using Technetium-99m-Labeled Tissue Plasminogen Activator
  • Fatty Acid Metabolic Imaging with Iodine-123-BMIPP for the Diagnosis of Coronary Artery Disease
Show more Human Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire